FI52861C - Förfarande för framställning av antimikrobiellt verksamma 2-(5-nitro-2 -imidazolyl)-bensimidazoler. - Google Patents

Förfarande för framställning av antimikrobiellt verksamma 2-(5-nitro-2 -imidazolyl)-bensimidazoler.

Info

Publication number
FI52861C
FI52861C FI701070A FI107070A FI52861C FI 52861 C FI52861 C FI 52861C FI 701070 A FI701070 A FI 701070A FI 107070 A FI107070 A FI 107070A FI 52861 C FI52861 C FI 52861C
Authority
FI
Finland
Prior art keywords
benzimidazoles
imidazolyl
nitro
preparation
antimicrobially active
Prior art date
Application number
FI701070A
Other languages
English (en)
Finnish (fi)
Other versions
FI52861B (sv
Inventor
Clemens Rufer
Eberhard Schroeder
Hans-Joachim Kessler
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI52861B publication Critical patent/FI52861B/fi
Application granted granted Critical
Publication of FI52861C publication Critical patent/FI52861C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/95—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by nitrogen atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/30—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds
    • C07C209/32—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds by reduction of nitro groups
    • C07C209/325—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds by reduction of nitro groups reduction by other means than indicated in C07C209/34 or C07C209/36
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/30—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds
    • C07C209/32—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds by reduction of nitro groups
    • C07C209/36—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds by reduction of nitro groups by reduction of nitro groups bound to carbon atoms of six-membered aromatic rings in presence of hydrogen-containing gases and a catalyst
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI701070A 1969-04-19 1970-04-17 Förfarande för framställning av antimikrobiellt verksamma 2-(5-nitro-2 -imidazolyl)-bensimidazoler. FI52861C (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1920635A DE1920635C3 (de) 1969-04-19 1969-04-19 2-(l-MethyI-5-nitro-2-imidazolyl)benzimidazole

Publications (2)

Publication Number Publication Date
FI52861B FI52861B (sv) 1977-08-31
FI52861C true FI52861C (sv) 1977-12-12

Family

ID=5732064

Family Applications (1)

Application Number Title Priority Date Filing Date
FI701070A FI52861C (sv) 1969-04-19 1970-04-17 Förfarande för framställning av antimikrobiellt verksamma 2-(5-nitro-2 -imidazolyl)-bensimidazoler.

Country Status (15)

Country Link
JP (1) JPS4914231B1 (sv)
AT (1) AT294075B (sv)
BE (1) BE749102A (sv)
CH (2) CH546774A (sv)
CS (1) CS167896B2 (sv)
DE (1) DE1920635C3 (sv)
DK (1) DK137758B (sv)
ES (1) ES378368A1 (sv)
FI (1) FI52861C (sv)
FR (1) FR2042351B1 (sv)
GB (1) GB1312056A (sv)
NL (1) NL7005703A (sv)
NO (1) NO126624B (sv)
SE (1) SE364962B (sv)
ZA (1) ZA702577B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053472A (en) * 1969-04-19 1977-10-11 Schering Aktiengesellschaft 2-(5-nitro-2-imidazolyl)-benzimidazoles
IT1043840B (it) * 1971-05-08 1980-02-29 Poli Ind Chimica Spa Pirimidine 2 5 disostituite e processo per la loro preparazione
US3996238A (en) * 1972-02-08 1976-12-07 Ciba-Geigy Corporation 4- or 5-Nitroimidazoles and processes for their manufacture
BE795636A (fr) * 1972-02-19 1973-08-20 Schering Ag Nitroimidazolylpyrimidines, et leur procede de preparation
PT78358B (en) * 1983-04-07 1986-05-30 Smith Kline French Lab Chemical process
CA2168016C (en) * 1994-05-31 2000-09-26 Akio Matsunaga Benzimidazole derivatives
EP0777656B1 (en) * 1994-08-26 2004-04-14 Auckland Division Cancer Society Of New Zealand (Incorporated) Novel dna-targeted alkylating agents

Also Published As

Publication number Publication date
DK137758B (da) 1978-05-01
AT294075B (de) 1971-11-10
FI52861B (sv) 1977-08-31
CH546774A (de) 1974-03-15
FR2042351B1 (sv) 1973-07-13
ES378368A1 (es) 1972-06-16
BE749102A (fr) 1970-10-19
DE1920635C3 (de) 1979-06-28
DE1920635A1 (de) 1970-10-29
CH546768A (de) 1974-03-15
JPS4914231B1 (sv) 1974-04-05
FR2042351A1 (sv) 1971-02-12
GB1312056A (en) 1973-04-04
ZA702577B (en) 1971-01-27
CS167896B2 (sv) 1976-05-28
DE1920635B2 (de) 1978-11-02
NL7005703A (sv) 1970-10-21
SE364962B (sv) 1974-03-11
DK137758C (sv) 1978-10-09
NO126624B (sv) 1973-03-05

Similar Documents

Publication Publication Date Title
FI49035C (sv) Förfarande för framställning av terapeutiskt användbart 2-brom-alfa-er gokryptin.
FI51046C (sv) Förfarande för framställning av acetocalisylsyratablett.
FI49716C (sv) Förfarande för framställning av 2,4-diamino-5-bensyl-pyrimidiner.
FI50334C (sv) Förfarande för framställning av 1-hydroxy-2-pyridoner.
FI52094C (sv) Förfarande för framställning av nya, antimikrobiskt verksamma, i 3-stä llningen substituerade derivat av 7-acylamino-kef-3-em-4-karbonsyra.
FI49512C (sv) Förfarande för framställning av nya terapeutiskt aktiva s-triazinyl-pi perazinderivat.
FI52861C (sv) Förfarande för framställning av antimikrobiellt verksamma 2-(5-nitro-2 -imidazolyl)-bensimidazoler.
FI47575C (sv) Analogiförfarande för framställning av evomonosid-derivat.
FI51179C (sv) Förfarande för framställning av nya hypoglykemiskt verksamma 1-(p-acyl aminoalkyl-fenylsulfonyl)-2-imino-imidazolidiner.
FI47489C (sv) Förfarande för framställning av inflammationsförhindrande 5-(1-aroyl-3 -indolyl-metyl)-tetrazoler.
FI45178C (sv) Förfarande för framställning av antidiabetiskt verksamma sulfonamider.
FI49161C (sv) Förfarande för framställning av kardenolid-3-(2´,3´-didesoxi-2´,3´-oxi do-glykosider).
FI47577C (sv) Förfarande för framställning av 2,4,7-triamino-6-fenyl-pteridiner.
FI51183C (sv) Förfarande för framställning av 2-hydroximetyl-3-karbonsyraamido-kinox alin-di-N-oxid-(1,4)-föreningar.
FI52862C (sv) Förfarande för framställning av nya antimikrobiella 3-(5-nitro-2-imida zolylmetylenamino)-2-oxazolidinoner.
FI46727C (sv) Förfarande för framställning av pyridazolderivat.
FI49417C (sv) Förfarande för framställning av farmakologiskt aktiva 2,3-dihydro-bens ofuran-2-karbonsyror.
FI52088C (sv) Förfarande för framställning av 3-(4-acyloxialkyl-1-piperazinyl)-karbo nylmetyl-2-bensotiazolinonderivat.
FI47349C (sv) Förfarande för framställning av 17alfa-propadienyl-17beta-hydroxi-ster oider.
FI49501C (sv) Förfarande för framställning av antibakteriellt verksamma N-vinylkinol oner.
FI51814C (sv) Förfarande för framställning av alfa-karboxibensylpenicillin.
FI46724C (sv) Förfarande för framställning av 1,18-dimetyl-5alfa-H-androst-1-enderiv at.
FI50879C (sv) Förfarande för framställning av terapeutiskt verksamma sybstituerade 3 -aminoacylamino-tiofener.
FI45954C (sv) Förfarande för framställning av terapeutiskt verkande bensensulfonylka rbamider.
FI50243C (sv) Förfarande för framställning av terapeutiskt verksamma N-substituerade 3-hydroxi-9-azamorfinan.